EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats

Klára Šíchová iD, Barbara Mallarino, Lucie Janečková, Petr Palivec, Magdaléna Vágnerová, Čestmír Vejmola, Marek Nikolič, Lucie Ladislavová, Kristýna Mazochová, Pavel Ryšánek, Martin Šíma, Adam Šafanda und 4 weitere

International Journal of Neuropsychopharmacology · 01.08.2025 · 28 (8)

DOI: 10.1093/ijnp/pyaf041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 11.07.2025. Verfasst von Klára Šíchová und 15 weiteren Autor:innen. Beteiligte Einrichtung: Psychedelic Research Centre, National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic. Hauptthemen laut MEDLINE: Behavior, Animal, Prepulse Inhibition, Dronabinol, Psychotropic Drugs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of the Interior of the Czech Republic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hexahydrocannabinol (HHC) is a new psychoactive substance known for its mind-altering effects and temporary legal status. It is widely used in parts of the Europe and United Kingdom as a legal alternative to ∆9-tetrahydrocannabinol, yet little research has explored its effects and safety. This study examined how HHC is processed in the body, its toxicity, and its impact on behavior in male Wistar rats.

Methods

A 1:1 mixture of (9R)-HHC and (9S)-HHC was administered via intragastric gavage at doses of 1, 5, and 10 mg/kg. Behavioral effects were assessed using the open field test and the prepulse inhibition of acoustic startle response.

Results

Two hours after the highest dose (10 mg/kg), peak concentrations of HHC were detected in blood and brain tissue. The Organization for Economic Co-operation and Development 423 toxicity test classified HHC as a Category 4 substance, estimating a lethal dose of 1000 mg/kg. Compared to controls (administered by sunflower oil), 10 mg/kg HHC reduced movement, increased anxiety, and impaired sensory processing.

Conclusions

Overall, HHC crosses the blood–brain barrier, exhibits mild toxicity, and induces behavioral effects similar to tetrahydrocannabinol. Its dose-dependent anxiogenic properties and impact on information processing highlight the importance of the appropriate dosing in any potential therapeutic use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Behavior, AnimalPrepulse InhibitionDronabinolPsychotropic DrugsCannabinolAnimalsRats, WistarMaleRatsReflex, StartleBrainDose-Response Relationship, DrugAnxiety

Stichwörter der Autor:innen

acute toxicitybehaviorhexahydrocannabinolpharmacokineticsrat

Substanzen

DronabinolPsychotropic DrugsCannabinol

Autor:innen und Institutionen

  • Psychedelic Research Centre, National Institute of Mental Health, Topolová 748, Klecany 250 67, Czech Republic.
  • Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, Prague 6 166 28, Czech Republic.
  • Department of Analytical Chemistry, University of Chemistry and Technology Prague, Technická 5, Prague 6 166 28, Czech Republic.
  • 3rd Faculty of Medicine, Charles University, Ruská 87, Prague 10 100 00, Czech Republic.
  • Institute of Pharmacology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Albertov 4, Prague 2 128 00, Czech Republic.
  • Institute of Pathology, 1st Faculty of Medicine, Charles University, Studničkova 2, Prague 2 128 00, Czech Republic.

ORCID-Profile: Klára Šíchová, Martin Kuchař, Tomáš Páleníček

Förderung

  • Ministry of the Interior of the Czech Republic

Zitieren

APA

Šíchová, K., Mallarino, B., Janečková, L., Palivec, P., Vágnerová, M., Vejmola, Č., Nikolič, M., Ladislavová, L., Mazochová, K., Ryšánek, P., Šíma, M., Šafanda, A., Hiep, B. Q., Koutrouli, I. R. A., Kuchař, M., & Páleníček, T. (2025). Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats. International Journal of Neuropsychopharmacology, 28(8). https://doi.org/10.1093/ijnp/pyaf041

Vancouver

Šíchová K, Mallarino B, Janečková L, Palivec P, Vágnerová M, Vejmola Č, et al. Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats. International Journal of Neuropsychopharmacology. 2025;28(8). doi:10.1093/ijnp/pyaf041

BibTeX
@article{chov2025,
  author = {Šíchová, Klára and Mallarino, Barbara and Janečková, Lucie and Palivec, Petr and Vágnerová, Magdaléna and Vejmola, Čestmír and Nikolič, Marek and Ladislavová, Lucie and Mazochová, Kristýna and Ryšánek, Pavel and Šíma, Martin and Šafanda, Adam and Hiep, Bui Quang and Koutrouli, Isis Rita Anzel and Kuchař, Martin and Páleníček, Tomáš},
  title = {Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2025},
  volume = {28},
  number = {8},
  doi = {10.1093/ijnp/pyaf041}
}
Kostenlos starten →